Significance: As the myopia epidemic unfolds, there is growing urgency to identify and implement effective interventions to slow myopia progression. This investigation evaluated the effectiveness of an evidence-based myopia treatment algorithm in a clinical setting among 342 consecutive children.
Purpose: This study aimed to evaluate effectiveness of a clinical treatment algorithm for myopia progression in children.
Purpose: To evaluate myopia progression over an approximately 6-year follow-up period in children and young adults wearing a commercially available, daily disposable, soft multifocal contact lens with an extended depth of focus (center distance) design.
Methods: This retrospective cohort analysis included data from 196 patients of mean (SD) age 12.3 (2.
Best practice clinical guidelines for myopia control involve an understanding of the epidemiology of myopia, risk factors, visual environment interventions, and optical and pharmacologic treatments, as well as skills to translate the risks and benefits of a given myopia control treatment into lay language for both the patient and their parent or caregiver. This report details evidence-based best practice management of the pre-, stable, and the progressing myope, including risk factor identification, examination, selection of treatment strategies, and guidelines for ongoing management. Practitioner considerations such as informed consent, prescribing off-label treatment, and guides for patient and parent communication are detailed.
View Article and Find Full Text PDFPurpose: Most studies have reported only minimal reductions in myopia progression with bifocal or progressive multifocal spectacles, although somewhat larger, although mostly still clinically insignificant, effects have been reported in children with nearpoint esophoria and/or accommodative dysfunctions. The CONTROL study was a 1-year, prospective, randomized, clinical trial of bifocal contact lenses for control of myopia in children with eso fixation disparities at near.
Methods: Eighty-six myopic subjects, aged 8 to 18 years, were enrolled in the study after passing the screening examination.
This article presents a clinical perspective on recent myopia research related to the development and testing of optical treatments for controlling myopia progression. The perspective is from that of a clinician in private practice and a clinician researcher, both with long-term involvement in myopia management and research.
View Article and Find Full Text PDFBackground: Several studies have suggested that bifocal and progressive spectacles can reduce progression of myopia in esophoric children. This study compared myopic progression with bifocal (BSCL) and single vision soft contact lenses (SVSCL) in identical twins with near point esophoria.
Methods: Two 12-year-old myopic girls were randomly assigned to wear either BSCL or SVSCL for one year using a double-masked design.